Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture
In this preliminary communication, published in Regenerative Medicine, learn more about an automated 'quality-by-design' approach for scalable production of human embryonic stem cells. This article has been made free exclusively for members of RegMedNet.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>